Zhejiang Jiuzhou Pharmaceutical Competitors and Similar CompaniesClear all

Zhejiang Jiuzhou Pharmaceutical's competitors and similar companies include Zydus Lifesciences, Interbat, Grupo Menarini and AOP Orphan Pharmaceuticals.

	Zhejiang Jiuzhou Pharmaceutical Zhejiang Jiuzhou Pharmaceutical (浙江九洲药业股份有限公司) is a manufacturer and supplier of pharmaceutical products.	Zydus Lifesciences Zydus Lifesciences (formerly known as Cadila Healthcare) is a company that provides healthcare solutions.	Interbat Interbat is a pharmaceutical company.	Grupo Menarini Grupo Menarini is a pharmaceutical company.	AOP Orphan Pharmaceuticals AOP Orphan is a company focused on clinical development, marketing and distribution of medicines for rare and complex diseases.
Founding Date	Founding Date 1973	Founding Date 1952	Founding Date 1948	Founding Date 1961	Founding Date 1996
Type	Type Public	Type Public	Type Private	Type Private	Type Private
Tags	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma	Tags Healthcare distribution drug development pharma
Locations	Locations Taizhou, CN HQ	Locations Ahmedabad, IN HQ Rio De Janeiro, BR Nanterre, FR Ahmedabad, IN Ambernath, IN Ankleshwar, IN Bengaluru, IN see more	Locations ID HQ	Locations Badalona, ES HQ	Locations Wien, AT HQ Sofia, BG Meudon, FR Ismaning, DE Athina, GR Budapest, HU see more
Employees	Employees 5,001	Employees 27,9176% increase	Employees 9272% increase	Employees 5541% increase	Employees 5352% increase
Financial
Revenue (est.)	Revenue (est.) ¥5.3b (FY, 2025)	Revenue (est.) ₹267.2b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods ¥3.5b (FY, 2025)	Cost of goods ₹72.9b (FY, 2026)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit ¥2b (FY, 2025)	Gross profit ₹203.7b (FY, 2026)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ¥728.5m (FY, 2025)	Net income ₹50.3b (FY, 2026)	Net income N/A	Net income N/A	Net income N/A